Status:
COMPLETED
Long-term Active Surveillance Study for Oral Contraceptives (LASS)
Lead Sponsor:
Center for Epidemiology and Health Research, Germany
Collaborating Sponsors:
Bayer
Conditions:
Arterial Thromboembolism
Venous Thromboembolism
Eligibility:
FEMALE
Brief Summary
The objective of this study is to characterize and compare the risks of long-term use of oral contraceptives containing drospirenone and of other established oral contraceptives.
Detailed Description
The LASS Study is a large, multinational, prospective, controlled, non-interventional, long-term cohort study that follows a series of cohorts. The cohorts consist of new users (first-ever users, swit...
Eligibility Criteria
Inclusion
- Women who are prescribed an oral contraceptive and who are new users (first-ever users, switchers or restarters) of the formulation
Exclusion
- Women who do not consent to participate in the study
Key Trial Info
Start Date :
February 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
58303 Patients enrolled
Trial Details
Trial ID
NCT00676065
Start Date
February 1 2001
End Date
December 1 2011
Last Update
November 19 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Epidemiology and Health Research
Berlin, Germany